Cover Image
市場調查報告書

印尼的醫藥品、醫療產業(季度更新報告)

Indonesia Pharmaceuticals and Healthcare Report Q2 2017

出版商 BMI Research 商品編碼 177846
出版日期 內容資訊 英文 124 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
印尼的醫藥品、醫療產業(季度更新報告) Indonesia Pharmaceuticals and Healthcare Report Q2 2017
出版日期: 2017年03月01日 內容資訊: 英文 124 Pages
簡介

本報告提供印尼的製藥、醫療產業結構和最新趨勢相關分析,今後10年的產業規模的動向估計,產業的課題(風險)和未來商機(利潤)相關評估,政府的政策、規定,宏觀經濟環境,主要企業簡介等資訊彙整,為您概述為以下內容。

BMI的見解

SWOT分析

產業預測

  • 醫藥品市場預測
  • 醫療市場預測
  • 處方藥市場預測
  • 專利藥市場預測
  • 學名藥市場預測
  • 成藥市場預測
  • 醫藥品的對外貿易情形

產業的風險/利潤、等級

  • 亞太地區:風險/利潤、等級
  • 印尼:風險/利潤、等級
    • 利潤
    • 風險

法規的檢討

  • 智慧財產權相關課題
  • 藥價
  • 償付

產業的趨勢與發展

  • 市場概要
  • 醫療部門
  • 研究開發
  • 臨床實驗
  • 流行病學

競爭情形

  • 研究開發
  • 學名藥
  • 醫藥品的流通部門
  • 醫藥品的零售部門

企業簡介

人口動態的預測

  • 人口動態預測

詞彙表

調查手法

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 1748-1945

BMI View: Indonesia's pharmaceutical sector will see continued foreign investment. Spurring even greater investment has been the relaxation of foreign ownership restrictions in both the 2014 and 2016 and revisions to the negative investment lists. This is further reinforced by regulations pushing for the localisation of pharmaceuticals, as well as by the attractiveness of the Indonesian market as the largest in South East Asia.

Headline Expenditure Projections

  • Pharmaceuticals: IDR85bntrn (USD6.4bn) in 2016 to IDR94trn (USD6.7bn) in 2017; +10.1% growth in local currency terms and +4.6 in US dollar terms.
  • Healthcare: IDR366trn (USD27bn) in 2016 to IDR406trn (USD28bn) in 2017; +10.9% growth in local currency terms and +5.4% in US dollar terms.

Risk/Reward Index

Indonesia ranks 11 out of 20 Asia Pacific markets on BMI's Pharmaceutical Risk/Reward Index, scoring 49.5 out of 100 in Q217. While the country has positive industry rewards, scoring 24.8 out of 44.0, it is dragged down by a low Country Reward score (10.2 out of 21), as well as higher Industry Risks (scoring 8.4 out of 21) and Country Risks (scoring 6.5 out of 14) scores.

Table of Contents

BMI Industry View

  • Table: Headline Pharmaceuticals & Healthcare Forecasts (Indonesia 2015-2021)
  • SWOT

Industry Forecast

  • Pharmaceutical Market Forecast
    • Table: Pharmaceutical Sales, Historical Data And Forecasts (Indonesia 2013-2021)
  • Healthcare Market Forecast
    • Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Indonesia 2013-2021)
    • Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Indonesia 2013-2021)
    • Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Indonesia 2013-2021)
  • Prescription Drug Market Forecast
    • Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Indonesia 2013-2021)
  • Patented Drug Market Forecast
    • Table: Patented Drug Market Indicators, Historical Data And Forecasts (Indonesia 2013-2021)
  • Generic Drug Market Forecast
    • Table: Generic Drug Market Indicators, Historical Data And Forecasts (Indonesia 2013-2021)
  • OTC Medicine Market Forecast
    • Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Indonesia 2013-2021)
  • Pharmaceutical Trade Forecast
    • Table: Pharmaceutical Trade Data And Forecasts (Indonesia 2015-2021)
    • Table: Pharmaceutical Trade Data And Forecasts local currency (Indonesia 2015-2021)

Industry Risk/Reward Index

  • Asia Pacific Risk/Reward Index
  • Indonesia Risk/Reward Index
    • Rewards
    • Risks

Regulatory Review

  • Intellectual Property Issues
  • Pricing Regime
  • Reimbursement Regime

Industry Trends And Developments

  • Market Overview
    • Table: UN Millennium Development Goals For Indonesia
  • Healthcare Sector
    • Table: Examples Of JKN Benefits
    • Table: Healthcare Resources (Indonesia 2011-2016)
    • Table: Healthcare Personnel (Indonesia 2011-2016)
    • Table: Healthcare Activity (Indonesia 2011-2016)
  • Research & Development
  • Clinical Trials
  • Epidemiology
    • Table: Estimated Number Of New Cases Of Cancer In Indonesia

Competitive Landscape

  • Research-Based Industry
    • Table: Selected List Of Pharmaceutical Business Areas With Restricted Conditions
    • Table: Multinational Market Activity
  • Generic Drugmakers
  • Pharmaceutical Distribution
  • Pharmaceutical Retail Sector

Company Profile

  • Bayer
  • Darya-Varia Group
  • GlaxoSmithKline
  • Indopharma
  • Kimia Farma
  • Merck & Co
  • Merck Group
  • Novartis
  • Pfizer
  • PT Biofarma
  • PT Kalbe Farma
  • Sanofi
  • Soho Group

Demographic Forecast

  • Demographic Outlook
    • Table: Population Headline Indicators (Indonesia 1990-2025)
    • Table: Key Population Ratios (Indonesia 1990-2025)
    • Table: Urban/Rural Population & Life Expectancy (Indonesia 1990-2025)
    • Table: Population By Age Group (Indonesia 1990-2025)
    • Table: Population By Age Group % (Indonesia 1990-2025)

Glossary

Methodology

  • Pharmaceutical Expenditure Forecast Model
  • Healthcare Expenditure Forecast Model
  • Notes On Methodology
  • Risk/Reward Index Methodology
  • Index Overview
    • Table: Pharmaceutical Risk/Reward Index Indicators
  • Indicator Weightings
Back to Top